Give me a sign, any sign

Thorax

Volumn 64, Issue 9, 2009, Pages 737-738

  Mazzone, Peter J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VOLATILE ORGANIC COMPOUND;

BREATH ANALYSIS; CANCER CELL; CONCENTRATION (PARAMETERS); DIAGNOSTIC ACCURACY; DISEASE COURSE; EDITORIAL; EXPIRED AIR; HUMAN; INHALATION; ION MOBILITY SPECTROMETRY; LIPID PEROXIDATION; LUNG CANCER; MASS FRAGMENTOGRAPHY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 69749097317     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2008.107409     Document Type: Editorial

References (22)

1. Pepe G, Rossetti C, Sironi S, et al. Patients with known or suspected lung cancer: evaluation of clinical management changes due to 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) study. Nucl Med Commun 2005;26:831-837 (Pubitemid 41215769)
2. Gildea TR, Mazzone PJ, Karnak D, et al. Electromagnetic navigation diagnostic bronchoscopy. A prospective study. Am J Respir Crit Care Med 2006;174:982-989 (Pubitemid 44684446)
3. Wallace MB, Pascual JMS, Raimondo M, et al. Minimally invasive endoscopic staging of suspected lung cancer. JAMA 2008;299:540-546 (Pubitemid 351214251)
4. Eberhard DA, Giaccone G, Johnson BE. Biomarkers of response to epidermal growth factor receptor inhibitors in non-small-cell lung cancer working group: standardization for use in the clinical trial setting. J Clin Oncol 2008;26:983-994
5. Uemura M, Miyagawa M, Yasuhara Y, et al. Clinical evaluation of pulmonary nodules with dual-exposure dual-energy subtraction chest radiography. Radiat Med 2005;23:391-397 (Pubitemid 41441898)
6. Johkoh T, Kozuka T, Tomiyama N, et al. Temporal subtraction for detection of solitary pulmonary nodules on chest radiographs: evaluation of a commercially available computer-aided diagnosis system. Radiology 2002;223:806-811 (Pubitemid 34547601)
7. Das M, Muhlenbruch G, Mahnken AH, et al. Small pulmonary nodules: effect of two computer-aided detection systems on radiologist performance. Radiology 2006;241:564-571 (Pubitemid 44632904)
8. Bolte H, Jahnke T, Schafer FKW, et al. Interobserver-variability of lung nodule volumetry considering different segmentation algorithms and observer training levels. Eur J Radiol 2007;64:285-295 (Pubitemid 47593063)
9. Shinagawa N, Yamazaki K, Onodera Y, et al. Factors related to diagnostic sensitivity using an ultrathin bronchoscope under CT guidance. Chest 2007;131:549-553 (Pubitemid 46280418)
10. Vincent BD, Fraig M, Silvestri GA. A pilot study of narrow-band imaging compared to white light bronchoscopy for evaluation of normal airways and premalignant and malignant airways disease. Chest 2007;131:1794-1799 (Pubitemid 46981636)
11. Coxson HO, Quiney B, Sin DD, et al. Airway wall thickness assessed using computed tomography and optical coherente tomography. Am J Respir Crit Care Med 2008;177:1201-1206 (Pubitemid 351860928)
12. Shedden K, Taylor JMG, Enkemann SA, et al. Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med 2008;14:822-827
13. Spira A, Beane JE, Shah V, et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med 2007;13:361-366 (Pubitemid 46376687)
14. Yanagisawa K, Shyr Y, Xu BJ, et al. Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 2003;362:433-439 (Pubitemid 36999706)
15. Yildiz PB, Shyr Y, Rahman JSM, et al. Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer. J Thorac Oncol 2007;2:893-901. (Pubitemid 47511591)
16. Brock MV, Hooker CM, Ota-Machida E, et al. DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med 2008;358:1118-1128
17. Maheswaran S, Sequist LV, Nagrath S, et al. Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 2008;359:1-12.
18. Chapman CJ, Murray A, McElveen JE, et al. Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. Thorax 2008;63:228-233
19. Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18:997-1006.
20. Carpagnano GE, Foschino-Barbaro MP, Spanevello A, et al. 3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer. Am J Respir Crit Care Med 2008;177:337-341 (Pubitemid 351198378)
21. Mazzone PJ. Analysis of volatile organic compounds in the exhaled breath for lung cancer diagnosis. J Thorac Oncol 2008;3:774-780
22. Westhoff M, Litterst P, Freitag L, et al. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Thorax 2009;64:744-748